Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Executive Officer, Director
-
Stock Symbol
-
HRTX on Nasdaq
Craig Collard - trading volume in the past year for Heron Therapeutics, Inc. /De/
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
277K |
$730K |
$2.64 |
Jul 19, 2024 |
Direct |
|
|
| Restricted Stock Units |
193K |
$510K |
$2.64 |
Jul 19, 2024 |
Direct |
Common Stock |
|
| Employee Stock Option (Right to Buy) |
1.32M |
|
|
Jan 19, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.